Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
The Active Site cover art

The Active Site

The Active Site

Written by: William Wallace Ph.D.
Listen for free

About this listen
The Active Site is an investigative science show hosted by Dr. William Wallace, examining the claims shaping health, medicine, nutrition, and human biology. Through scientific history, landmark studies, hidden contradictions, competing interpretations, and unresolved questions, each episode asks not only whether a belief is true—but how we came to believe it in the first place.


© 2026 The Active Site
Biological Sciences Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Is Inflammation the New Cholesterol?
    Nov 17 2026

    For decades, cholesterol has been blamed for heart disease, but some have argued that inflammation is the real culprit. In 2017 that idea got what looked like proof, when a drug cut heart attacks by calming inflammation while cholesterol stayed exactly where it was. A major cardiology group now recommends testing everyone's inflammation level alongside their cholesterol. Then, in November 2026, the biggest test yet of that idea reported its results. This investigation follows the evidence from inside the artery wall to that trial to find out whether inflammation really is the new cholesterol.


    TIMESTAMPS


    0:00 The trial that broke the pattern
    2:33 Telling a marker from a cause
    4:43 The case for inflammation
    7:59 Where the story gets complicated
    10:20 Searching for an explanation
    11:39 What this means for you

    Show More Show Less
    14 mins
  • Are GLP-1s Longevity Drugs?
    Nov 10 2026

    GLP-1 drugs like Ozempic are usually discussed as weight-loss medicines. But in October 2025, a testing company announced that semaglutide had reversed biological age by 3.1 years, and in 2026, a study in Nature reported that old female mice given the drug lived longer. The story of these drugs began with a gut hormone the body destroys in about two minutes, a lizard venom, and heart safety trials that were never meant to find a benefit. This investigation follows that evidence from the original discovery to the latest human trials to determine what GLP-1 drugs actually do, and whether their reputation as longevity drugs has been earned.

    TIMESTAMPS
    0:00 Intro
    0:48 The two-minute hormone
    1:33 The Gila monster discovery
    2:29 The heart safety scare
    4:02 Ozempic becomes a weight-loss drug
    4:42 The SELECT and FLOW trials
    6:13 Where the 3.1 years came from
    7:48 The Alzheimer's trials
    8:56 Old mice lived longer
    10:22 What happens when people stop
    11:34 What the evidence actually shows

    Show More Show Less
    13 mins
  • The Nicotine–Parkinson’s Paradox
    Sep 8 2026

    Nicotine is usually discussed as an addictive drug. But in 1959, researchers noticed something unexpected: people who smoked appeared less likely to develop Parkinson’s disease. That observation survived decades of scrutiny and eventually led to animal experiments, memory studies, nicotine patches, and major clinical trials. This investigation follows that evidence from the original anomaly to the latest human research to determine what nicotine actually does to the brain—and whether its neuroprotective reputation has been earned.

    Time Stamps

    0:00 – Intro
    1:44 – Reverse causation theory
    2:32 – The Swedish snus study
    4:00 – Animal trials: mice vs. monkeys
    5:16 – Nicotine's effect on the brain
    7:35 – The NIC-PD trial
    9:04 – The MIND trial
    11:31 – The 2009 paper that predicted the failure
    12:55 – What the evidence actually shows

    Show More Show Less
    14 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet